Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor

Authors:

Abstract
No abstract available
Funding Information
  • Takeda Pharmaceutical Company

This publication has 27 references indexed in Scilit: